[Business Wire] - Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today announced it awarded "inducement" options to two new employees under Rule 5635 of the NASDAQ Marketplace Rules as an inducement for entering into employment with the Company.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment